Deals23 Apr 2025, 09:00 pm
Panacea Biotec Ltd. Receives Additional US$ 5.20 Million Award from UNICEF for bOPV Supply
AI Summary
Panacea Biotec Ltd. has received an additional Award from UNICEF for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 5.20 million (~Rs.44 Crore) in Q3 CY2025. This is in continuation to the earlier award received for supply of 115 million doses of bOPV worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025. The existing Long Term Arrangement between UNICEF and the Company will be amended accordingly.
Key Highlights
- Additional Award from UNICEF for supply of 40 million doses of bOPV worth ~US$ 5.20 million (~Rs.44 Crore) in Q3 CY2025
- In continuation to the earlier award received for supply of 115 million doses of bOPV worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025
- Existing Long Term Arrangement between UNICEF and the Company will be amended accordingly